| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.5B | $1.4B | $1.4B | $1.3B | $0.2B | $0.2B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $-0.0B | $0.0B | $0.0B |
| Net Income | $-0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.4B | $4.8B | $4.8B | $4.7B | $4.1B | $2.5B | $2.3B | $2.2B |
| Current Assets | $2.4B | $1.6B | $1.5B | $1.8B | $2.4B | $1.4B | $1.4B | $1.3B |
| Cash & Equivalents | $1.6B | $0.7B | $0.8B | $1.3B | $1.5B | $1.1B | $1.1B | $0.9B |
| Total Liabilities | $4.6B | $4.0B | $4.0B | $3.7B | $3.1B | $1.5B | $1.4B | $1.4B |
| Current Liabilities | $4.5B | $4.0B | $4.0B | $3.6B | $3.1B | $1.5B | $1.3B | $1.3B |
| Stockholders' Equity | $0.9B | $0.9B | $0.8B | $1.1B | $1.0B | $0.9B | $0.9B | $0.8B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B |
| Investing Cash Flow | $0.1B | $0.0B | $-0.8B | $-1.4B | $-0.8B | $-0.2B | $-0.1B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $0.7B | $-0.3B | $0.0B | $1.0B | $1.0B | $-0.1B | $-0.1B | $0.2B |